搜索结果
疾病ID:TCMBANKDI000802
疾病名:Pruritus
MeSH_Name:Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
HPO_Name:Abnormality of the integument
UMLS_Name:Finding
DO_Name:-
疾病类型:phenotype
DisGeNET_Link:C0033774
MeSH_Link:C23; C17
HPO_Link:HP:0001574
UMLS_Link:T033
DO_Link:-
HERB_ID:HBDIS002499
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE012778 | DCLRE1C | A-SCID; DCLREC1C; RS-SCID; SCIDA; SNM1C | DNA cross-link repair 1C |
| TCMBANKGE001409 | ZNF341 | HIES3 | zinc finger protein 341 |
| TCMBANKGE001111 | KIT | C-Kit; CD117; MASTC; PBT; SCFR | KIT proto-oncogene, receptor tyrosine kinase |
| TCMBANKGE013382 | ADA | - | adenosine deaminase |
| TCMBANKGE014824 | TNFSF15 | TL1; TL1A; TNLG1B; VEGI; VEGI192A | TNF superfamily member 15 |
| TCMBANKGE012974 | SLC17A9 | C20orf59; POROK8; VNUT | solute carrier family 17 member 9 |
| TCMBANKGE006813 | TET2 | KIAA1546; MDS | tet methylcytosine dioxygenase 2 |
| TCMBANKGE003095 | F2RL1 | GPR11; PAR2 | F2R like trypsin receptor 1 |
| TCMBANKGE010791 | MVD | FP17780; MDDase; MPD; POROK7 | mevalonate diphosphate decarboxylase |
| TCMBANKGE005766 | PMVK | HUMPMKI; PMK; PMKA; PMKASE; POROK1 | phosphomevalonate kinase |
| TCMBANKGE008380 | IRF5 | SLEB10 | interferon regulatory factor 5 |
| TCMBANKGE000917 | IL17RA | CANDF5; CD217; CDw217; IL-17RA; IL17R; IMD51; hIL-17R | interleukin 17 receptor A |
| TCMBANKGE001052 | NLRP3 | AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1 | NLR family pyrin domain containing 3 |
| TCMBANKGE007397 | SH2B3 | IDDM20; LNK | SH2B adaptor protein 3 |
| TCMBANKGE014188 | HRH4 | AXOR35; BG26; GPCR105; GPRv53; H4; H4R; HH4R | histamine receptor H4 |
| TCMBANKGE000500 | EPHX1 | EPHX; EPOX; HYL1; MEH | epoxide hydrolase 1 |
| TCMBANKGE014170 | PNPLA1 | ARCI10; dJ50J22.1 | patatin like phospholipase domain containing 1 |
| TCMBANKGE006889 | FECH | EPP; EPP1; FCE | ferrochelatase |
| TCMBANKGE003699 | GSN | ADF; AGEL | gelsolin |
| TCMBANKGE001020 | TJP2 | C9DUPq21.11; DFNA51; DUP9q21.11; PFIC4; X104; ZO2 | tight junction protein 2 |
| TCMBANKGE008431 | OSMR | IL-31R-beta; IL-31RB; OSMRB; OSMRbeta; PLCA1 | oncostatin M receptor |
| TCMBANKGE010653 | FLI1 | BDPLT21; EWSR2; SIC-1 | Fli-1 proto-oncogene, ETS transcription factor |
| TCMBANKGE004052 | CCDC47 | GK001; MSTP041; THNS | coiled-coil domain containing 47 |
| TCMBANKGE000042 | GPR35 | - | G protein-coupled receptor 35 |
| TCMBANKGE013175 | SCN11A | FEPS3; HSAN7; NAV1.9; NaN; PN5; SCN12A; SNS-2 | sodium voltage-gated channel alpha subunit 11 |
| TCMBANKGE004513 | LIPA | CESD; LAL | lipase A, lysosomal acid type |
| TCMBANKGE012767 | ATP7B | PWD; WC1; WD; WND | ATPase copper transporting beta |
| TCMBANKGE008140 | MVK | LRBP; MK; MVLK; POROK3 | mevalonate kinase |
| TCMBANKGE011999 | PEPD | PROLIDASE | peptidase D |
| TCMBANKGE014647 | IL7R | CD127; CDW127; IL-7R-alpha; IL7RA; ILRA | interleukin 7 receptor |
| TCMBANKGE006914 | DCDC2 | DCDC2A; DFNB66; NPHP19; NSC; RU2; RU2S | doublecortin domain containing 2 |
| TCMBANKGE001278 | CERS3 | ARCI9; LASS3 | ceramide synthase 3 |
| TCMBANKGE003435 | HSD3B7 | CBAS1; PFIC4; SDR11E3 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
| TCMBANKGE014764 | EPOR | EPO-R | erythropoietin receptor |
| TCMBANKGE005030 | STX3 | STX3A | syntaxin 3 |
| TCMBANKGE014996 | POU2AF1 | BOB1; OBF-1; OBF1; OCAB | POU class 2 homeobox associating factor 1 |
| TCMBANKGE005969 | THPO | MGDF; MKCSF; ML; MPLLG; THCYT1; TPO | thrombopoietin |
| TCMBANKGE011325 | CYP4F22 | ARCI5; INLNE; LI3 | cytochrome P450 family 4 subfamily F member 22 |
| TCMBANKGE001178 | STAT3 | ADMIO; ADMIO1; APRF; HIES | signal transducer and activator of transcription 3 |
| TCMBANKGE010809 | ABCB4 | ABC21; GBD1; ICP3; MDR2; MDR2/3; MDR3; PFIC-3; PGY3 | ATP binding cassette subfamily B member 4 |
| TCMBANKGE000297 | JAK2 | JTK10; THCYT3 | Janus kinase 2 |
| TCMBANKGE007385 | NRAS | ALPS4; CMNS; N-ras; NCMS; NRAS1; NS6 | NRAS proto-oncogene, GTPase |
| TCMBANKGE014531 | ENPP1 | ARHR2; COLED; M6S1; NPP1; NPPS; PC-1; PCA1; PDNP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
| TCMBANKGE011901 | AQP5 | AQP-5; PPKB | aquaporin 5 |
| TCMBANKGE001989 | GPC1 | glypican | glypican 1 |
| TCMBANKGE011937 | LIPN | ARCI8; LI4; LIPL4; bA186O14.3 | lipase family member N |
| TCMBANKGE000163 | TNFRSF1B | CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR | TNF receptor superfamily member 1B |
| TCMBANKGE009478 | MYO5B | - | myosin VB |
| TCMBANKGE010462 | ALOX12B | 12R-LOX; ARCI2 | arachidonate 12-lipoxygenase, 12R type |
| TCMBANKGE009842 | FDPS | FPPS; FPS; POROK9 | farnesyl diphosphate synthase |
| TCMBANKGE012446 | IL2RG | CD132; CIDX; IL-2RG; IMD4; P64; SCIDX; SCIDX1 | interleukin 2 receptor subunit gamma |
| TCMBANKGE003866 | ABCA12 | ARCI4A; ARCI4B; ICR2B; LI2 | ATP binding cassette subfamily A member 12 |
| TCMBANKGE001697 | MMP1 | CLG; CLGN | matrix metallopeptidase 1 |
| TCMBANKGE000951 | CYP7B1 | CBAS3; CP7B; SPG5A | cytochrome P450 family 7 subfamily B member 1 |
| TCMBANKGE008702 | OPRM1 | LMOR; M-OR-1; MOP; MOR; MOR1; OPRM | opioid receptor mu 1 |
| TCMBANKGE001199 | PDGFRA | CD140A; PDGFR-2; PDGFR2 | platelet derived growth factor receptor alpha |
| TCMBANKGE011521 | CLEC7A | BGR; CANDF4; CD369; CLECSF12; DECTIN1; SCARE2 | C-type lectin domain containing 7A |
| TCMBANKGE002475 | SDR9C7 | ARCI13; RDHS; SDR-O; SDRO | short chain dehydrogenase/reductase family 9C member 7 |
| TCMBANKGE012203 | FH | FMRD; HLRCC; HsFH; LRCC; MCL; MCUL1 | fumarate hydratase |
| TCMBANKGE005353 | NLRC4 | AIFEC; CARD12; CLAN; CLAN1; CLANA; CLANB; CLANC; CLAND; CLR2.1; FCAS4; IPAF | NLR family CARD domain containing 4 |
| TCMBANKGE002920 | GPNMB | HGFIN; NMB; PLCA3 | glycoprotein nmb |
| TCMBANKGE007624 | CD28 | Tp44 | CD28 molecule |
| TCMBANKGE001816 | HRH1 | H1-R; H1R; HH1R; hisH1 | histamine receptor H1 |
| TCMBANKGE002000 | CTLA4 | ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12 | cytotoxic T-lymphocyte associated protein 4 |
| TCMBANKGE002584 | CHD7 | CRG; HH5; IS3; KAL5 | chromodomain helicase DNA binding protein 7 |
| TCMBANKGE006470 | MPL | C-MPL; CD110; MPLV; THCYT2; THPOR; TPOR | MPL proto-oncogene, thrombopoietin receptor |
| TCMBANKGE008826 | LBR | C14SR; DHCR14B; LMN2R; PHA; PHASK; TDRD18 | lamin B receptor |
| TCMBANKGE004727 | TRAF3IP2 | ACT1; C6orf2; C6orf4; C6orf5; C6orf6; CANDF8; CIKS; PSORS13 | TRAF3 interacting protein 2 |
| TCMBANKGE010831 | BAAT | BACAT; BAT | bile acid-CoA:amino acid N-acyltransferase |
| TCMBANKGE009234 | COL7A1 | EBD1; EBDCT; EBR1; NDNC8 | collagen type VII alpha 1 chain |
| TCMBANKGE008270 | MST1 | D3F15S2; DNF15S2; HGFL; MSP; NF15S2 | macrophage stimulating 1 |
| TCMBANKGE006006 | RAG2 | RAG-2 | recombination activating 2 |
| TCMBANKGE010737 | MMEL1 | MMEL2; NEP2; NEPII; NL1; NL2; SEP | membrane metalloendopeptidase like 1 |
| TCMBANKGE014865 | ATP2A2 | ATP2B; DAR; DD; SERCA2 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
| TCMBANKGE000586 | IL17F | CANDF6; IL-17F; ML-1; ML1 | interleukin 17F |
| TCMBANKGE000504 | IL12A | CLMF; IL-12A; NFSK; NKSF1; P35 | interleukin 12A |
| TCMBANKGE002727 | ALOXE3 | ARCI3; E-LOX; eLOX-3; eLOX3 | arachidonate lipoxygenase 3 |
| TCMBANKGE004675 | CARD14 | BIMP2; CARMA2; PRP; PSORS2; PSS1 | caspase recruitment domain family member 14 |
| TCMBANKGE009780 | SULT2B1 | ARCI14; HSST2 | sulfotransferase family 2B member 1 |
| TCMBANKGE000180 | TCF4 | CDG2T; E2-2; FECD3; ITF-2; ITF2; PTHS; SEF-2; SEF2; SEF2-1; SEF2-1A; SEF2-1B; SEF2-1D; TCF-4; bHLHb19 | transcription factor 4 |
| TCMBANKGE009967 | DSG4 | CDGF13; CDHF13; HYPT6; LAH | desmoglein 4 |
| TCMBANKGE005805 | MC1R | CMM5; MSH-R; SHEP2 | melanocortin 1 receptor |
| TCMBANKGE011390 | IL17RC | CANDF9; IL17-RL; IL17RL | interleukin 17 receptor C |
| TCMBANKGE000778 | TAC1 | Hs.2563; NK2; NKNA; NPK; TAC2 | tachykinin precursor 1 |
| TCMBANKGE007167 | LIG4 | LIG4S | DNA ligase 4 |
| TCMBANKGE004834 | HLA-DRA | HLA-DRA1 | major histocompatibility complex, class II, DR alpha |
| TCMBANKGE011864 | TGM1 | ARCI1; ICR2; KTG; LI; LI1; TGASE; TGK | transglutaminase 1 |
| TCMBANKGE000106 | SCN10A | FEPS2; Nav1.8; PN3; SNS; hPN3 | sodium voltage-gated channel alpha subunit 10 |
| TCMBANKGE000065 | SCN9A | ETHA; FEB3B; GEFSP7; HSAN2D; NE-NA; NENA; Nav1.7; PN1; SFNP | sodium voltage-gated channel alpha subunit 9 |
| TCMBANKGE009933 | TPSAB1 | TPS1; TPS2; TPSB1; TPSB2; Tryptase-2 | tryptase alpha/beta 1 |
| TCMBANKGE000954 | ABCB11 | ABC16; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP | ATP binding cassette subfamily B member 11 |
| TCMBANKGE000763 | TRPV3 | FNEPPK2; OLMS; VRL3 | transient receptor potential cation channel subfamily V member 3 |
| TCMBANKGE010481 | ATP8B1 | ATPIC; BRIC; FIC1; ICP1; PFIC; PFIC1 | ATPase phospholipid transporting 8B1 |
| TCMBANKGE001772 | ABCC6 | ABC34; ARA; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; PXE; PXE1; URG7 | ATP binding cassette subfamily C member 6 |
| TCMBANKGE013156 | PTPN3 | PTP-H1; PTPH1 | protein tyrosine phosphatase non-receptor type 3 |
| TCMBANKGE002626 | SPIB | SPI-B | Spi-B transcription factor |
滇IICP备16009434号-1 |
Dai SX Lab